(3.239.56.184) 您好!臺灣時間:2021/05/13 12:20
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:林映廷
研究生(外文):Ying-Ting
論文名稱:紫檀芪對Heregulin-β1誘導之人類乳癌細胞侵襲能力的影響
論文名稱(外文):Effects of pterostilbene on heregulin-β1-induced human breast cancer cells invasiveness
指導教授:陳威仁陳威仁引用關係
學位類別:碩士
校院名稱:中山醫學大學
系所名稱:生物醫學科學學系碩士班
學門:生命科學學門
學類:生物化學學類
論文種類:學術論文
論文出版年:2008
畢業學年度:96
語文別:中文
論文頁數:31
相關次數:
  • 被引用被引用:0
  • 點閱點閱:153
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
國人十大死亡原因的首位為惡性腫瘤,其中乳癌是導致女性癌症致死率的第四位,癌症致死的主因在於癌細胞的擴散。因此,能有效的抑制乳癌細胞侵襲及轉移的發生機制,對於治療預後不良的乳癌患者將具有重大意義。乳癌細胞中,HER2接受器常有基因擴大表現的現象,進而促使癌細胞不斷的進行分化、增殖、血管新生以及轉移;而HRG-β1是屬於表皮生長因子-ligand家族中的成員,在乳癌組織中同樣具有過度表現的情形,可誘發細胞膜上HER family的訊息傳遞,因此在乳癌生成的過程中扮演非常重要的角色。基質金屬蛋白酶 (matrix metalloproteinases, MMPs),是一群鋅依賴性的蛋白質水解酵素,目前發現的種類已超過20種,此群酵素幾乎能降解細胞外基質的所有成份,因此被認為與癌細胞之侵襲與轉移息息相關。研究發現,乳癌的復發或轉移和HER family 所引起的MMP-9過度表現具有相關性。植物多酚類之一的白藜蘆醇 (resveratrol) 證實具有抗發炎、抗氧化、抗腫瘤轉移等多種生物活性。近來,發現紫檀芪(pterostilbene)為白藜蘆醇的結構類似物,推測和白藜蘆醇可能具有類似的生理活性。目前初步研究已知紫檀芪可促使癌細胞產生凋亡,其在抗癌作用機制中仍不清楚。因此,本研究主要目的是想探討紫檀芪是否具有類似白藜蘆醇的抗腫瘤轉移的作用。在本研究中發現,紫檀芪對HRG-β1刺激人類乳癌細胞株MCF-7侵犯及轉移的能力皆具有濃度依賴性的抑制效果。另外,在明膠水解試驗及西方墨點法個別分析MMP-9的酵素活性及蛋白表現中也呈現相同的抑制趨勢。實驗結果發現,紫檀芪可明顯降低人類乳癌細胞中HER2/HER3蛋白質酪胺酸的磷酸化,並且會減少彼此形成複合體的情形。綜合以上結果,本研究發現紫檀芪確實具有抑制乳癌細胞轉移的能力,但詳細作用機轉仍需要更多研究來證實。


In Taiwan, breast cancer is one of the highly dangerous causes of death for females due to tumor metastasis and invasion which can be up-regulated by growth factor receptor such as human epidermal growth factor receptor 2 (HER2). Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases which degrade a variety of extracellular matrix components, have been considered to promote tumor metastasis and invasion. Among them, the expression of MMP-9 mediated by HER2 or its related ligand such as heregulin-β1 (HRG-β1, a combinatorial ligand for the HER3 and HER4 receptors can transactivate HER2 receptor) has been shown to be highly associated with breast cancer metastasis, suggesting that MMP-9 may be an accessible target for improving the health of breast cancer patients under metastatic progression.

Pterostilbene, a dimethyl ether analogue of resveratrol, exerts its cancer chemopreventive activity similar to resveratrol by inhibiting cancer cell proliferation and inducing apoptosis. Recent study has shown that resveratrol blocks HRG-β1-modulated MMP-9 expression and invasion in human breast cancer cells, raising the possibility that pterostilbene might prevent cancer cell metastasis or invasion. To this end, the effects of pterostilbene on HRG-β1-mediated cell invasion in MCF-7 human breast cancer cells were examined.

In this study, we found that pterostilbene reduced HRG-β1-mediated cell invasion and migration in a dose-dependent manner in MCF-7 cells, demonstrated by transwell assay and wound healing assay, respectively. Soft agar assay shows that pterostilbene inhibited HRG-β1-stimulated tumorigenicity of MCF-7 cells. Pterostilbene also inhibited the enzyme activity and protein expression of MMP-9 by HRG-β1, analyzed by gelatin zymography and western blotting, respectively. Furthermore, pterostilbene clearly decreased either HER2 or HER3 tyrosine phosphorylation, and interrupted the formation of heterodimer between HER2 and HER3 in HRG-β1-treated MCF-7 cells.

Taken together, our present results indicate that pterostilbene has an inhibitory potential on HRG-β1-mediated cell invasion and metastasis of breast cancer cells, which might be attributed to inhibition of MMP-9 expression and HER2 signaling by pterostilbene. However, the detailed mechanisms by which pterostilbene down-regulates MMP-9 expression and cell invasion require further study.



致謝
目錄 Ⅰ.
中文摘要 Ⅲ.
英文摘要 Ⅴ.
縮寫表 Ⅶ.
壹、緒論
一、乳癌與表皮生長因子接受器家族的關係……………………1
二、基質金屬蛋白酶與癌症轉移的相關性………………………2
三、MAPKs訊息傳遞路徑與癌症之關聯………………………… 3
四、紫檀芪 (Pterostilbene) 的簡介…………………………4
五、研究動機………………………………………………………5
貳、材料與方法
一、人類乳癌細胞株 (MCF-7 cell line) 的培養………6
二、西方墨點法 (Western Blotting)……………………6
三、明膠水解分析 (Gelatin zymography)………………8
四、細胞侵襲能力試驗 (Cell invasion assay)…………8
五、免疫沈澱法 (Immunopreciptation)…………………9
六、固著非依賴性生長分析 (Anchorage-independent growth assay) ……………………………………………………………9
七、傷口癒合試驗 (Wound healing assay)…………..10
Ⅰ.
參、結果………………………………………………………….11
肆、討論………………………………………………………….18
伍、附圖………………………………………………………….23
參考文獻………………………………………………………….32



1.Ullrich, A. and J. Schlessinger, Signal transduction by receptors with tyrosine kinase activity. Cell, 1990. 61(2): p. 203-12.

2.Olayioye, M.A., et al., The ErbB signaling network: receptor heterodimerization in development and cancer. The EMBO Journal, 2000. 19(13): p. 3159-67.

3.O-charoenrat, P., et al., The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncology, 2002. 38(7): p. 627-40.

4.Guy, P.M., et al., Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proceedings of the National Academy of Sciences of the United States of America, 1994. 91(17): p. 8132-6.

5.Alimandi, M., et al., Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene, 1995. 10(9): p. 1813-21.

6.deFazio, A., et al., Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. International journal of cancer. Journal international du cancer, 2000. 87(4): p. 487-98.

7.Naidu, R., et al., Expression of c-erbB3 protein in primary breast carcinomas. British Journal of Cancer, 1998. 78(10): p. 1385-90.

8.Woodhouse, E.C., R.F. Chuaqui, and L.A. Liotta, General mechanisms of metastasis. Cancer, 1997. 80(8 Suppl): p. 1529-37.

9.Chambers, A.F., A.C. Groom, and I.C. MacDonald, Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2002. 2(8): p. 563-72.

10.Hanahan, D. and R.A. Weinberg, The hallmarks of cancer. Cell, 2000. 100(1): p. 57-70.

11.Pantel, K. and R.H. Brakenhoff, Dissecting the metastatic cascade. Nature Reviews. Cancer, 2004. 4(6): p. 448-56.

12.Chambers, A.F. and L.M. Matrisian, Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute, 1997. 89(17): p. 1260-70.

13.Duffy, M.J. and K. McCarthy, Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review). International Journal of Oncology, 1998. 12(6): p. 1343-8.

14.Egeblad, M. and Z. Werb, New functions for the matrix metalloproteinases in cancer progression. Nature Reviews. Cancer, 2002. 2(3): p. 161-74.

15.Sternlicht, M.D. and Z. Werb, How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology, 2001. 17: p. 463-516.

16.Lee, P.P., et al., Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology, 2000. 141(10): p. 3764-73.

17.Waas, E.T., et al., Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. British Journal of Cancer, 2002. 86(12): p. 1876-83.

18.Brew, K., D. Dinakarpandian, and H. Nagase, Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica Et Biophysica Acta, 2000. 1477(1-2): p. 267-83.

19.Nagase, H. and J.F. Woessner, Matrix metalloproteinases. The Journal of Biological Chemistry, 1999. 274(31): p. 21491-4.

20.Basset, P., et al., Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biology: Journal of the International Society for Matrix Biology, 1997. 15(8-9): p. 535-41.

21.Johnsen, M., et al., Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Current Opinion in Cell Biology, 1998. 10(5): p. 667-71.

22.Rimando, A.M., et al., Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. Journal of Agricultural and Food Chemistry, 2002. 50(12): p. 3453-7.

23.Jang, M. and J.M. Pezzuto, Cancer chemopreventive activity of resveratrol. Drugs Under Experimental and Clinical Research, 1999. 25(2-3): p. 65-77.

24.Pace-Asciak, C.R., et al., Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clinica Chimica Acta; International Journal of Clinical Chemistry, 1996. 246(1-2): p. 163-82.

25.Soleas, G.J., E.P. Diamandis, and D.M. Goldberg, Wine as a biological fluid: history, production, and role in disease prevention. Journal of Clinical Laboratory Analysis, 1997. 11(5): p. 287-313.

26.Suh, N., et al., Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 2007. 13(1): p. 350-5.

27.Tsai, M.-S., et al., Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene, 2003. 22(5): p. 761-8.

28.Price, J.E., Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms. Journal of the National Cancer Institute, 1986. 77(2): p. 529-35.

29.Yao, J., et al., Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene, 2001. 20(56): p. 8066-74.

30.Scorilas, A., et al., Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. British Journal of Cancer, 2001. 84(11): p. 1488-96.

31.Tang, F.-Y., E.-P.I. Chiang, and Y.-C. Sun, Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. The Journal of Nutritional Biochemistry, 2008. 19(5): p. 287-94.

32.Yu, H., et al., Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy, 2008. 62(6): p. 366-72.

33.Lupu, R., et al., The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Research and Treatment, 1996. 38(1): p. 57-66.

34.Tsai, M.-S., et al., Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene, 2003. 22(5): p. 761-8.

35.Price, J.E., Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms. Journal of the National Cancer Institute, 1986. 77(2): p. 529-35.


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文
 
系統版面圖檔 系統版面圖檔